Loading…

EphrinB3 and EphrinB4 Receptors are potential therapeutic targets in glioblastoma

Saved in:

Bibliographic Details
Published in:	Canadian journal of neurological sciences 2015-12, Vol.42 (S3), p.S4-S4
Main Authors:	Kumar, R. Sreeraman, Macaulay, R.J.B., Rutherford, H.C., Barkey, N., Koomen, J., Morse, D.L.
Format:	Article
Language:	English
Subjects:	Abstracts Brain cancer Tumors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page	S4
container_issue	S3
container_start_page	S4
container_title	Canadian journal of neurological sciences
container_volume	42
creator	Kumar, R. Sreeraman Macaulay, R.J.B. Rutherford, H.C. Barkey, N. Koomen, J. Morse, D.L.
description
doi_str_mv	10.1017/cjn.2015.373
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2799749412</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_cjn_2015_373</cupid><sourcerecordid>2799749412</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1423-33009b0d2dec5fab4bc1d24158f97aba8aa2e1d7a6aaa7ba830efff72819a5fa3</originalsourceid><addsrcrecordid>eNptkE1LAzEURYMoWKs7f0DArTPmayadpZZWhYIoug5vMkmbMp2MSbrw35vSghtXjwvn3gcHoVtKSkqofNDboWSEViWX_AxNGKlkkWN1jiaEU1nQWtJLdBXjlhBWV7WYoPfFuAlueOIYhg6fgsAfRpsx-RAxBINHn8yQHPQ4bUyA0eyT0zhBWJsUsRvwune-7SEmv4NrdGGhj-bmdKfoa7n4nL8Uq7fn1_njqtBUMF5wTkjTko51RlcWWtFq2jFBq5ltJLQwA2CGdhJqAJA5c2KstZLNaAO5wKfo7rg7Bv-9NzGprd-HIb9UTDaNFI2gLFP3R0oHH2MwVo3B7SD8KErUQZrK0tRBmsrSMl6ecNi1wXVr87f6b-EXBu9vow</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2799749412</pqid></control><display><type>article</type><title>EphrinB3 and EphrinB4 Receptors are potential therapeutic targets in glioblastoma</title><source>Cambridge University Press</source><creator>Kumar, R. Sreeraman ; Macaulay, R.J.B. ; Rutherford, H.C. ; Barkey, N. ; Koomen, J. ; Morse, D.L.</creator><creatorcontrib>Kumar, R. Sreeraman ; Macaulay, R.J.B. ; Rutherford, H.C. ; Barkey, N. ; Koomen, J. ; Morse, D.L.</creatorcontrib><identifier>ISSN: 0317-1671</identifier><identifier>EISSN: 2057-0155</identifier><identifier>DOI: 10.1017/cjn.2015.373</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Abstracts ; Brain cancer ; Tumors</subject><ispartof>Canadian journal of neurological sciences, 2015-12, Vol.42 (S3), p.S4-S4</ispartof><rights>Copyright © The Canadian Journal of Neurological Sciences Inc. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S031716711500373X/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,72709</link.rule.ids></links><search><creatorcontrib>Kumar, R. Sreeraman</creatorcontrib><creatorcontrib>Macaulay, R.J.B.</creatorcontrib><creatorcontrib>Rutherford, H.C.</creatorcontrib><creatorcontrib>Barkey, N.</creatorcontrib><creatorcontrib>Koomen, J.</creatorcontrib><creatorcontrib>Morse, D.L.</creatorcontrib><title>EphrinB3 and EphrinB4 Receptors are potential therapeutic targets in glioblastoma</title><title>Canadian journal of neurological sciences</title><addtitle>Can. J. Neurol. Sci</addtitle><subject>Abstracts</subject><subject>Brain cancer</subject><subject>Tumors</subject><issn>0317-1671</issn><issn>2057-0155</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNptkE1LAzEURYMoWKs7f0DArTPmayadpZZWhYIoug5vMkmbMp2MSbrw35vSghtXjwvn3gcHoVtKSkqofNDboWSEViWX_AxNGKlkkWN1jiaEU1nQWtJLdBXjlhBWV7WYoPfFuAlueOIYhg6fgsAfRpsx-RAxBINHn8yQHPQ4bUyA0eyT0zhBWJsUsRvwune-7SEmv4NrdGGhj-bmdKfoa7n4nL8Uq7fn1_njqtBUMF5wTkjTko51RlcWWtFq2jFBq5ltJLQwA2CGdhJqAJA5c2KstZLNaAO5wKfo7rg7Bv-9NzGprd-HIb9UTDaNFI2gLFP3R0oHH2MwVo3B7SD8KErUQZrK0tRBmsrSMl6ecNi1wXVr87f6b-EXBu9vow</recordid><startdate>201512</startdate><enddate>201512</enddate><creator>Kumar, R. Sreeraman</creator><creator>Macaulay, R.J.B.</creator><creator>Rutherford, H.C.</creator><creator>Barkey, N.</creator><creator>Koomen, J.</creator><creator>Morse, D.L.</creator><general>Cambridge University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>201512</creationdate><title>EphrinB3 and EphrinB4 Receptors are potential therapeutic targets in glioblastoma</title><author>Kumar, R. Sreeraman ; Macaulay, R.J.B. ; Rutherford, H.C. ; Barkey, N. ; Koomen, J. ; Morse, D.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1423-33009b0d2dec5fab4bc1d24158f97aba8aa2e1d7a6aaa7ba830efff72819a5fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Abstracts</topic><topic>Brain cancer</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, R. Sreeraman</creatorcontrib><creatorcontrib>Macaulay, R.J.B.</creatorcontrib><creatorcontrib>Rutherford, H.C.</creatorcontrib><creatorcontrib>Barkey, N.</creatorcontrib><creatorcontrib>Koomen, J.</creatorcontrib><creatorcontrib>Morse, D.L.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Canadian journal of neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, R. Sreeraman</au><au>Macaulay, R.J.B.</au><au>Rutherford, H.C.</au><au>Barkey, N.</au><au>Koomen, J.</au><au>Morse, D.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EphrinB3 and EphrinB4 Receptors are potential therapeutic targets in glioblastoma</atitle><jtitle>Canadian journal of neurological sciences</jtitle><addtitle>Can. J. Neurol. Sci</addtitle><date>2015-12</date><risdate>2015</risdate><volume>42</volume><issue>S3</issue><spage>S4</spage><epage>S4</epage><pages>S4-S4</pages><issn>0317-1671</issn><eissn>2057-0155</eissn><cop>New York, USA</cop><pub>Cambridge University Press</pub><doi>10.1017/cjn.2015.373</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0317-1671
ispartof	Canadian journal of neurological sciences, 2015-12, Vol.42 (S3), p.S4-S4
issn	0317-1671 2057-0155
language	eng
recordid	cdi_proquest_journals_2799749412
source	Cambridge University Press
subjects	Abstracts Brain cancer Tumors
title	EphrinB3 and EphrinB4 Receptors are potential therapeutic targets in glioblastoma
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T16%3A18%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EphrinB3%20and%20EphrinB4%20Receptors%20are%20potential%20therapeutic%20targets%20in%20glioblastoma&rft.jtitle=Canadian%20journal%20of%20neurological%20sciences&rft.au=Kumar,%20R.%20Sreeraman&rft.date=2015-12&rft.volume=42&rft.issue=S3&rft.spage=S4&rft.epage=S4&rft.pages=S4-S4&rft.issn=0317-1671&rft.eissn=2057-0155&rft_id=info:doi/10.1017/cjn.2015.373&rft_dat=%3Cproquest_cross%3E2799749412%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1423-33009b0d2dec5fab4bc1d24158f97aba8aa2e1d7a6aaa7ba830efff72819a5fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2799749412&rft_id=info:pmid/&rft_cupid=10_1017_cjn_2015_373&rfr_iscdi=true